FierceBiotech6d
Glucotrack’s 3-year diabetes sensor implant clears initial human safety trial
Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...
Hosted on MSN9mon
GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying
This article GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying originally appeared on Benzinga.com.
drugdeliverybusiness7d
Glucotrack completes first-in-human continuous blood glucose monitor implant study
Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose ...
Seeking Alpha7d
Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor
Glucotrack (NASDAQ:GCTK) on Tuesday reported the successful completion of its first in human clinical study, sending shares up ~60% in the morning trade. This study represents first real-time ...
GlucoTrack prices offering of 2.6M shares of common stock at $1.15
Glucotrack (GCTK) announced the pricing of a “best efforts” public offering of approximately 2.6M shares of common stock. The offering price of ...
Glucotrack sets terms for $3 million public stock offering
RUTHERFORD, NJ - Glucotrack, Inc. (NASDAQ:GCTK), a developer of medical technologies for diabetes care, has announced the pricing of its public offering at $1.15 per share, aiming to raise ...
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...